0001493152-22-026582.txt : 20220922 0001493152-22-026582.hdr.sgml : 20220922 20220922173835 ACCESSION NUMBER: 0001493152-22-026582 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220920 FILED AS OF DATE: 20220922 DATE AS OF CHANGE: 20220922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liu James Yang CENTRAL INDEX KEY: 0001944774 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 221260190 MAIL ADDRESS: STREET 1: C/O ONCOCYTE CORPORATION STREET 2: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncocyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-409-7600 MAIL ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20200213 FORMER COMPANY: FORMER CONFORMED NAME: Oncocyte Corp DATE OF NAME CHANGE: 20200205 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20150513 3 1 ownership.xml X0206 3 2022-09-20 0 0001642380 Oncocyte Corp OCX 0001944774 Liu James Yang 15 CUSHING IRVINE CA 92618 0 1 0 0 Controller, PAO Option to Purchase Common Stock 1.15 2032-03-15 Common Stock 10000 D Option to Purchase Common Stock 1.39 2032-03-24 Common Stock 2260 D Option to Purchase Common Stock 0.887 2032-09-20 Common Stock 75000 D 25% of the options will become exercisable after one year of Reporting Person's continuous employment with Issuer from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to Reporting Person's continued employment with Issuer on the applicable vesting dated. /s/ James Liu 2022-09-22